Search

Private investment in the biotech industry up 20% from 2020. The figures were announced at AseBio Investor Day 2022, which brought together over 50 investors from all over Europe and more than 260

The Spanish start-up Real Deal Milk (RDM), based in the Barcelona Science park, has opened a €2 million funding round that will go towards boosting R&D activity and expanding its lab, which is located

Participants and sponsors of AseBio Investor Day 2022, just two days away, give us some tips for setting up a biotech company from academia

PharmaBoardroom, a leading British media specialized in the health sector, has published an article in which it highlights VIVEbiotech as one of the ten Spanish biotechs to follow in 2022.

In his new role, Hosseiney will be responsible for the oversight and continued growth of NBD's Global Operations

The facilities of the Biotechnology Business Incubator (Bioincubator), located in Castilla y León at the Boecillo Technology Park in Valladolid, Spain, are fully prepared for the start of activity

Aiming to protect human health and the environment, Kimitec, has been researching and developing for the last 15 years natural solutions capable of replacing synthetic chemicals in food production

After just three months since the incorporation of DIVERSA Technologies, the company has already struck some deals that will bolster its commercial activities within Europe

BIOLAN launches a new analytical solution that allows to quantitatively classify the degree of YAKE in tuna, without the need to defrost and generate damage in the piece, and digitally monitor its

ZeClinics has recently started a new collaboration with the Institut de la Vision, led by Filippo del Bene, to test in zebrafish the most cutting-edge genetic modification technologies

ZeClinics and Dompé Farmaceutici started this collaboration a few years ago, in an effort to validate the use of zebrafish to reliably model human retinopathies and, most importantly, to test

GMP is the highest quality seal that certifies that the Spanish biotechnology company complies with the Good Manufacturing Practices for the manufacture of pharmaceutical products in the European

BO-112 demonstrates potential as new and highly effective second line therapy for melanoma

Almirall recently announced collaboration agreements with the University of Michigan to accelerate the understanding of the factors that trigger hidradenitis suppurativa

BCN HEALTH has published 11 studies in 2021 assessing the incidence and cost of illness of different diseases in Spain

The biopharmaceutical company, based at the BIC Bizkaia bioincubator, is also supplying its investigational biological drug MBK-01 under compassionate use

The upcoming edition of this event will be held on 28 April in Madrid, with over 300 participants and 50 investors from all over Europe